$121 Billion Worldwide Cytokine Industry to 2027 – Featuring AbbVie, Abcam, Amgen and Applied Biological Materials Among Others

The “Cytokine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to  ResearchAndMarkets.com’s offering.

The global cytokine market reached a value of US$ 76.67 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 121.25 Billion by 2027, exhibiting a CAGR of 7.94% during 2021-2027.

Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor. 

A cytokine refers to a group of proteins, peptides, or glycoproteins released by specific cells to control the growth and activity of the immune system and blood cells. It can regulate immunity, inflammation, and hematopoiesis on account of its high-affinity picomolar concentrations. It is usually injected under the skin or into muscles or veins to help prevent or manage chemotherapy side effects and treat cancer. It also boosts anti-cancer activities by sending signals that make abnormal cells die and normal cells live longer. Presently, it is gaining widespread adoption in cell and gene therapy for the expansion and differentiation of various cell types, ex vivo cultures, and other therapeutic approaches.

The coronavirus disease (COVID-19) is transmitted via droplets that can induce the excessive production of proinflammatory cytokines and lead to acute respiratory distress syndrome (ARDS) aggravation and tissue damage. As tissue damage can result in multi-organ failure and death, there is a rise in the demand for solutions that target cytokines to manage patients, improve survival rates, and reduce mortality.

Apart from this, the increasing prevalence of cancer, in confluence with the escalating demand for minimally invasive surgeries (MIS) that provide less post-operative pain and complications and faster recovery time, is contributing to the market growth.

Moreover, as cytokines act as diagnostic, prognostic, and therapeutic agents and biomarkers for health and diseases, they are gaining traction in diverse functions, including immune cell differentiation, inflammation, angiogenesis, tumorigenesis, neurobiology, and viral pathogenesis. Besides this, the rising cases of atopic dermatitis (AD), a recurrent, chronic, and inflammatory skin disease that processes with severe itchiness, is driving the demand for new cytokines in the pathogenesis of AD and developing improved therapeutic targets.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Abcam plc, Amgen Inc., Applied Biological Materials Inc. (abm), Bio-Techne Corporation, F. Hoffmann-La Roche AG, GenScript Biotech Corporation, Randox Laboratories Ltd., Thermo Fisher Scientific Inc. and UCB S.A.

Key Questions Answered in This Report:

  • How has the global cytokine market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global cytokine market?
  • What are the key regional markets?
  • What is the breakup of the market based on the cytokine type?
  • What is the breakup of the market based on the therapeutic application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global cytokine market and who are the key players?
  • What is the degree of competition in the industry?

Key Topics Covered: 

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Cytokine Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Cytokine Type
6.1 Tumor Necrosis Factor-TNF
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Interleukins-Il
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Interferons-IFN
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Epidermal Growth Factor-EGF
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast

7 Market Breakup by Therapeutic Application
7.1 Cancer
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Asthma and Airway Inflammation
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Arthritis
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast

8 Market Breakup by End User
8.1 Pharmaceutical and Biotechnology Companies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Contract Research Organizations
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Academic and Research Institutes
8.3.1 Market Trends
8.3.2 Market Forecast

9 Market Breakup by Region

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 AbbVie Inc. Company Overview Product Portfolio Financials SWOT Analysis
14.3.2 Abcam plc Company Overview Product Portfolio Financials SWOT Analysis
14.3.3 Amgen Inc. Company Overview Product Portfolio Financials
14.3.4 Applied Biological Materials Inc. (abm) Company Overview Product Portfolio
14.3.5 Bio-Techne Corporation Company Overview Product Portfolio Financials
14.3.6 F. Hoffmann-La Roche AG Company Overview Product Portfolio Financials
14.3.7 GenScript Biotech Corporation Company Overview Product Portfolio
14.3.8 Randox Laboratories Ltd. Company Overview Product Portfolio
14.3.9 Thermo Fisher Scientific Inc. Company Overview Product Portfolio Financials SWOT Analysis
14.3.10 UCB S.A. Company Overview Product Portfolio Financials

For more information about this report visit https://www.researchandmarkets.com/r/1vex7t

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets

Leave a Reply

Your email address will not be published. Required fields are marked *